Gefitinib plus Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a …

X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… The incidence rates of adverse events were compared using … gefitinib plus FZKA had lower
incidences of adverse events … the adverse events of gefitinib but did not reduce its efficacy. …

[HTML][HTML] 晚期EGFR 突变型非小细胞肺癌患者接受吉非替尼或厄洛替尼治疗的成本效益分析

马宇翔, 黄岩, 赵洪云, 刘俊玲, 陈丽昆… - Chinese Journal of …, 2013 - ncbi.nlm.nih.gov
compare the effectiveness and prognosis of advanced NSCLC with gefitinib or erlotinib, as
well as the cost-effectiveness … The adverse reaction was milder in gefitinib group than that of …

埃克替尼与吉非替尼治疗EGFR 突变型晚期肺腺癌的临床疗效比较.

巫丽丽, 朱莹丽, 卓小露, 黄莉捺… - Chinese Journal of …, 2022 - search.ebscohost.com
… [Abstract] Objective To compare the clinical efficacy, adverse events, and immunological …
icotinib and gefitinib in the treatment of advanced lung adenocarcinoma patients with epidermal …

[HTML][HTML] EGFR-TKI 一线治疗EGFR 基因突变的晚期非小细胞肺癌临床观察

李俭杰, 曲莉莉, 卫星, 高红军, 王伟霞… - Chinese Journal of …, 2012 - ncbi.nlm.nih.gov
… The patients were first-line treated with oral administration of … The efficacy and adverse
events were observed, and … ; E: PFS comparing between gefitinib and erlotinib; F: OS comparing

[HTML][HTML] 新辅助化疗, 靶向治疗联合手术治疗临床Ⅲ 期EGFR 阳性肺腺癌

赵晨, 张辉, 刘冬, 张淼, 武文斌… - 中华胸部外科电子 …, 2021 - zhxbwkdzzz.cma-cmc.com.cn
… To investigate the safety and efficacy of neoadjuvant chemotherapy and targeted therapy …
significant difference (P>0.05) ; there was significant difference in tumor differentiation between

[引用][C] The value analysis of blood brain barrier permeability in the treatment of multiple brain metastases patients with non-small cell lung cancer

Z Yongli, D Jigang, L Bo, L Maojiang, C Yan… - J. Mod. Oncol, 2017

第一代抗表皮生长因子受体靶向药物对驱动基因阳性非小细胞肺癌的临床疗效

高金锁, 王建冰, 刘玮玮 - 中国临床研究, 2021 - zglcyj.cnjournals.com
gefitinib,imported gefitinib and erlotinib were respectively given in icotinib group,domestic …
significant differences in progression free survival and in cost-effectiveness analysis among

EGFR 敏感突变的晚期肺腺癌一线化疗与吉非替尼联合治疗的随机对照研究

金波, 张岩巍, 韩宝惠 - 中国癌症杂志, 2015 - china-oncology.com
… This study aimed to compare efficacy and safety of gefitinib … objective response rate and
adverse events. Results: Groups … Ⅱ trial of sequential erlotinib and gemcitabine compared with …

吉非替尼与厄洛替尼治疗非小细胞肺癌脑转移的临床观察

白皓, 熊丽纹, 韩宝惠, 姜丽岩 - 临床肿瘤学杂志, 2015 - manu65.magtech.com.cn
… ] Objective To evaluate clinical efficacy and prognosis of gefitinib and erlotinib against brain
compare the difference between two drugs. Methods A total of67 brain metastases patients

[PDF][PDF] 恩度联合EGFR-TKI 治疗老年非小细胞肺癌的临床观察

林秋菊, 张敏, 李文慧, 程鑫, 魏红梅 - 临床与病理杂志, 2020 - cdn.amegroups.cn
… 45 patients were given oral Iressa 250 mg qd or Tarceva 150 … patients in the combined drug
group evaluated the efficacy, … Table 3 Comparison of adverse reaction rates between the 2 …